ZION Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now at $60 for an impatient buyer. The stock is sitting near its pivot (59.89) with limited immediate upside before resistance (61.6–62.7), momentum isn’t clearly bullish (MACD still negative), and options positioning shows heavier put open interest (OI put/call 1.46) alongside notable insider selling. Positive capital return news (dividend + $75M buyback) is supportive, but the setup is more “wait for a better entry / confirmation” than “buy now.”
Intellectia Proprietary Trading Signals
Trend/momentum is mixed-to-slightly weak near-term. MACD histogram is below zero (-0.202) but contracting (downside momentum is fading, not reversed). RSI(6) ~55.6 is neutral (no overbought/oversold edge). Moving averages are converging, consistent with consolidation/indecision rather than a clean uptrend.
Key levels: Pivot 59.89 is being defended. Near-term support: 58.17 (S1), then 57.12 (S2). Near-term resistance: 61.61 (R1), then 62.66 (R2). From an execution standpoint, buying here offers modest room to resistance (2–4%) versus downside to support (~3–5%) if the pivot fails.
Quant pattern note provided: odds skew to mild weakness next day/week (-2.49% / -3.46%) but constructive 1-month (+7.03%), implying choppy near-term tape with better payoff if you can tolerate timing risk.
Capital return catalyst: declared $0.45 quarterly dividend and authorized $75M share repurchase for Q1 2026 (supports downside and signals confidence).
Fundamental tone from recent commentary: analysts cite Q4 beat, margin expansion, commercial loan growth, stable fees/expenses, and expectations for positive operating leverage.
Macro tailwind narrative for regionals: steepening yield curve / improving loan growth cited across bank-sector notes (helps NII outlook if it persists).
Insider activity: insiders are selling, with selling amount up ~838.6% over the last month (not a timing tool alone, but a meaningful near-term sentiment drag).
Options positioning: elevated put open interest (put/call OI 1.
implies ongoing hedging demand.
Technical overhang: price is close to pivot with MACD still negative; a break below ~59.9 risks a quick move toward 58.2/57.
No strong proprietary buy signals today (neither AI Stock Picker nor SwingMax), reducing the case for an “impatient buy-now” trade.
Latest provided quarter: 2025/Q3. Revenue rose to $888M (+15.78% YoY), net income to $218M (+7.92% YoY), and EPS to $1.48 (+8.03% YoY). This shows solid top-line growth with slower (but still positive) earnings growth—consistent with improving fundamentals, though not explosive acceleration.
Recent trend: price targets have generally been nudged up into the low-to-mid $60s after results (Citi to $64, Truist to $63, RBC to $64, TD Cowen to $64, Piper/Stephens to $65, UBS to $63). The notable outlier is Goldman reiterating Buy and raising PT to $70. Evercore downgraded to In Line (PT $65) citing limited near-term catalysts and valuation reflecting the outlook.
Wall Street pros: improving fundamentals (loan growth, margin expansion, operating leverage potential) and capital return support. Wall Street cons: valuation/near-term catalyst scarcity for multiple firms, and credit risk remains the key wildcard. Overall stance across the list is mostly Neutral/Hold with one prominent bullish call (GS), which argues for “okay stock, not an urgent buy at this exact level.”
